| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Adipocytokine signaling pathway 4 genes, 2 drugs (DrugBank), 11 diseases shown |
[3] CPT1A, CPT1B, CPT1C |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 2 | Adrenergic signaling in cardiomyocytes 9 genes, 9 drugs (DrugBank), 27 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 3 | African trypanosomiasis 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 4 | AGE-RAGE signaling pathway in diabetic complications 6 genes, 5 drugs (DrugBank), 26 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [5] CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 5 | Alcoholism 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ADORA2A |
D05711 |
Regadenoson |
[1] 58 |
| [2] ADORA2A, ADORA2B |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| 6 | Aldosterone synthesis and secretion 5 genes, 6 drugs (DrugBank), 24 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 7 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank), 6 diseases shown |
[1] NR3C2 |
D00443 |
Spironolactone |
[6] 58, 67, 86, 113, 218, 225 |
| 8 | Allograft rejection 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 9 | Alzheimer disease 12 genes, 5 drugs (DrugBank), 51 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [2] IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] MME |
D10225 |
Sacubitril |
[1] 58 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 10 | Amoebiasis 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 11 | Amphetamine addiction 7 genes, 3 drugs (DrugBank), 47 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 12 | AMPK signaling pathway 5 genes, 3 drugs (DrugBank), 20 diseases shown |
[1] ADRA1A |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [3] CPT1A, CPT1B, CPT1C |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 13 | Amyotrophic lateral sclerosis (ALS) 6 genes, 2 drugs (DrugBank), 48 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 14 | Antifolate resistance 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 15 | Antigen processing and presentation 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 16 | Apelin signaling pathway 1 gene, 4 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 17 | Apoptosis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 18 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 19 | Asthma 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 20 | Autoimmune thyroid disease 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL10 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 21 | Axon guidance 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 22 | B cell receptor signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 23 | Bile secretion 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 24 | C-type lectin receptor signaling pathway 9 genes, 2 drugs (DrugBank), 48 diseases shown |
[4] IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 25 | Calcium signaling pathway 16 genes, 12 drugs (DrugBank), 63 diseases shown |
[1] ADORA2A |
D05711 |
Regadenoson |
[1] 58 |
| [2] ADORA2A, ADORA2B |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [3] ADRA1A, ADRA1B, ADRA1D |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 26 | cAMP signaling pathway 7 genes, 6 drugs (DrugBank), 15 diseases shown |
[2] ADORA1, ADORA2A |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [1] ADORA2A |
D05711 |
Regadenoson |
[1] 58 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 27 | Carbohydrate digestion and absorption 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 28 | Cardiac muscle contraction 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 29 | Cellular senescence 8 genes, 4 drugs (DrugBank), 51 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [2] IL1A, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 30 | cGMP-PKG signaling pathway 16 genes, 11 drugs (DrugBank), 63 diseases shown |
[2] ADORA1, ADORA3 |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [3] ADRA1A, ADRA1B, ADRA1D |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 31 | Chagas disease (American trypanosomiasis) 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 32 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] CCL2 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 33 | Cholinergic synapse 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 34 | Circadian entrainment 2 genes, 2 drugs (DrugBank), 4 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 35 | Cortisol synthesis and secretion 5 genes, 6 drugs (DrugBank), 24 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 36 | Cushing syndrome 5 genes, 6 drugs (DrugBank), 24 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 37 | Cytokine-cytokine receptor interaction 6 genes, 1 drug (DrugBank), 10 diseases shown |
[6] CCL2, IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 38 | Cytosolic DNA-sensing pathway 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 39 | Dilated cardiomyopathy (DCM) 6 genes, 5 drugs (DrugBank), 20 diseases shown |
[1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 40 | Dopaminergic synapse 5 genes, 3 drugs (DrugBank), 47 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [3] PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 41 | EGFR tyrosine kinase inhibitor resistance 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 42 | Epstein-Barr virus infection 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 43 | Fatty acid degradation 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] CPT1A, CPT1B, CPT1C, CPT2 |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 44 | Fatty acid metabolism 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] CPT1A, CPT1B, CPT1C, CPT2 |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 45 | Fc epsilon RI signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 46 | Fluid shear stress and atherosclerosis 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] CCL2, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 47 | FoxO signaling pathway 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 48 | GABAergic synapse 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 49 | Gap junction 1 gene, 2 drugs (DrugBank), 8 diseases shown |
[1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| 50 | Glucagon signaling pathway 8 genes, 2 drugs (DrugBank), 45 diseases shown |
[3] CPT1A, CPT1B, CPT1C |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 51 | Glutamatergic synapse 7 genes, 3 drugs (DrugBank), 47 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 52 | GnRH secretion 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 53 | GnRH signaling pathway 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 54 | Graft-versus-host disease 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 55 | Growth hormone synthesis, secretion and action 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 56 | Hematopoietic cell lineage 5 genes, 2 drugs (DrugBank), 10 diseases shown |
[4] IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [1] MME |
D10225 |
Sacubitril |
[1] 58 |
| 57 | Hepatitis B 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 58 | Hepatitis C 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 59 | Herpes simplex virus 1 infection 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 60 | HIF-1 signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 61 | Human cytomegalovirus infection 9 genes, 2 drugs (DrugBank), 48 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 62 | Human immunodeficiency virus 1 infection 6 genes, 2 drugs (DrugBank), 48 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 63 | Human papillomavirus infection 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 64 | Human T-cell leukemia virus 1 infection 7 genes, 2 drugs (DrugBank), 48 diseases shown |
[2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 65 | Hypertrophic cardiomyopathy (HCM) 6 genes, 3 drugs (DrugBank), 13 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 66 | IL-17 signaling pathway 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 67 | Inflammatory bowel disease (IBD) 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 68 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL1B |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 69 | Influenza A 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 70 | Insulin resistance 4 genes, 2 drugs (DrugBank), 11 diseases shown |
[2] CPT1A, CPT1B |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [2] IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 71 | Insulin secretion 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 72 | Intestinal immune network for IgA production 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 73 | JAK-STAT signaling pathway 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 74 | Kaposi sarcoma-associated herpesvirus infection 6 genes, 2 drugs (DrugBank), 48 diseases shown |
[1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 75 | Legionellosis 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 76 | Leishmaniasis 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] IL10, IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 77 | Long-term potentiation 6 genes, 3 drugs (DrugBank), 47 diseases shown |
[1] CACNA1C |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 78 | Malaria 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 79 | MAPK signaling pathway 12 genes, 4 drugs (DrugBank), 51 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 80 | Measles 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 81 | Metabolic pathways 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 82 | Morphine addiction 1 gene, 1 drug (DrugBank), 5 diseases shown |
[1] ADORA1 |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| 83 | mTOR signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 84 | Natural killer cell mediated cytotoxicity 6 genes, 2 drugs (DrugBank), 48 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 85 | Necroptosis 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 86 | Neuroactive ligand-receptor interaction 9 genes, 9 drugs (DrugBank), 26 diseases shown |
[4] ADORA1, ADORA2A, ADORA2B, ADORA3 |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [1] ADORA2A |
D05711 |
Regadenoson |
[1] 58 |
| [3] ADRA1A, ADRA1B, ADRA1D |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 87 | NF-kappa B signaling pathway 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 88 | NOD-like receptor signaling pathway 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 89 | Non-alcoholic fatty liver disease (NAFLD) 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 90 | Oocyte meiosis 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 91 | Osteoclast differentiation 8 genes, 2 drugs (DrugBank), 48 diseases shown |
[3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 92 | Oxytocin signaling pathway 9 genes, 3 drugs (DrugBank), 47 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 93 | Parkinson disease 1 gene, 2 drugs (DrugBank), 5 diseases shown |
[1] ADORA2A |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| D05711 |
Regadenoson |
[1] 58 |
| 94 | Pathogenic Escherichia coli infection 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 95 | Pathways in cancer 2 genes, 5 drugs (DrugBank), 26 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 96 | PD-L1 expression and PD-1 checkpoint pathway in cancer 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 97 | Pertussis 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 98 | Phospholipase D signaling pathway 1 gene, 4 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| 99 | PI3K-Akt signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 100 | PPAR signaling pathway 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] CPT1A, CPT1B, CPT1C, CPT2 |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 101 | Prion diseases 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 102 | Protein digestion and absorption 1 gene, 1 drug (DrugBank), 1 disease shown |
[1] MME |
D10225 |
Sacubitril |
[1] 58 |
| 103 | Proteoglycans in cancer 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 104 | Rap1 signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] ADORA2A |
D05711 |
Regadenoson |
[1] 58 |
| [2] ADORA2A, ADORA2B |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| 105 | Regulation of lipolysis in adipocytes 2 genes, 3 drugs (DrugBank), 12 diseases shown |
[1] ADORA1 |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| 106 | Renin secretion 12 genes, 10 drugs (DrugBank), 62 diseases shown |
[1] ADORA1 |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 107 | Renin-angiotensin system 2 genes, 5 drugs (DrugBank), 21 diseases shown |
[1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [1] MME |
D10225 |
Sacubitril |
[1] 58 |
| 108 | Retrograde endocannabinoid signaling 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 109 | Rheumatoid arthritis 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] CCL2, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 110 | RIG-I-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 111 | Salivary secretion 4 genes, 3 drugs (DrugBank), 9 diseases shown |
[3] ADRA1A, ADRA1B, ADRA1D |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [1] ADRB1 |
D00632 |
Dobutamine |
[3] 57, 58, 215 |
| D03879 |
| D03880 |
| D03881 |
| D00601 |
Metoprolol |
[7] 17, 57, 58, 66, 113, 193, 226 |
| D02358 |
| D05011 |
| 112 | Salmonella infection 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1A, IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 113 | Serotonergic synapse 4 genes, 2 drugs (DrugBank), 4 diseases shown |
[4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 114 | Shigellosis 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 115 | Sphingolipid signaling pathway 3 genes, 2 drugs (DrugBank), 13 diseases shown |
[2] ADORA1, ADORA3 |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 116 | Staphylococcus aureus infection 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL10 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 117 | Systemic lupus erythematosus 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 118 | T cell receptor signaling pathway 7 genes, 2 drugs (DrugBank), 48 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 119 | Taste transduction 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1C |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 120 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 121 | TGF-beta signaling pathway 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 122 | Th1 and Th2 cell differentiation 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 123 | Th17 cell differentiation 7 genes, 2 drugs (DrugBank), 48 diseases shown |
[2] IL1B, IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 124 | Thermogenesis 4 genes, 1 drug (DrugBank), 2 diseases shown |
[4] CPT1A, CPT1B, CPT1C, CPT2 |
D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 125 | Tight junction 1 gene, 2 drugs (DrugBank), 4 diseases shown |
[1] CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 126 | TNF signaling pathway 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] CCL2, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 127 | Toll-like receptor signaling pathway 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 128 | Toxoplasmosis 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] IL10, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 129 | Transcriptional misregulation in cancer 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] IL6 |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 130 | Tuberculosis 10 genes, 2 drugs (DrugBank), 48 diseases shown |
[5] IL10, IL1A, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 131 | Type I diabetes mellitus 3 genes, 1 drug (DrugBank), 10 diseases shown |
[3] IL1A, IL1B, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 132 | Type II diabetes mellitus 3 genes, 3 drugs (DrugBank), 13 diseases shown |
[2] CACNA1C, CACNA1D |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| [1] TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 133 | Vascular smooth muscle contraction 10 genes, 9 drugs (DrugBank), 27 diseases shown |
[1] ADORA2A |
D05711 |
Regadenoson |
[1] 58 |
| [2] ADORA2A, ADORA2B |
D00045 |
Adenosine |
[5] 13, 46, 53, 58, 65 |
| [3] ADRA1A, ADRA1B, ADRA1D |
D01307 |
Midodrine |
[3] 6, 17, 58 |
| D08220 |
| [1] AGTR1 |
D00522 |
Candesartan |
[2] 58, 67 |
| D00522 |
Candesartan cilexetil |
[2] 58, 67 |
| D00626 |
| D00357 |
Losartan |
[18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |
| D00400 |
Valsartan |
[6] 57, 58, 66, 75, 218, 222 |
| [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S |
D00616 |
Diltiazem |
[3] 58, 86, 130 |
| D03830 |
| D07845 |
| D05442 |
Perhexiline |
[2] 58, 272 |
| D08340 |
| 134 | VEGF signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 135 | Viral protein interaction with cytokine and cytokine receptor 4 genes, 1 drug (DrugBank), 10 diseases shown |
[4] CCL2, IL10, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
| 136 | Wnt signaling pathway 5 genes, 1 drug (DrugBank), 44 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| 137 | Yersinia infection 5 genes, 1 drug (DrugBank), 10 diseases shown |
[5] CCL2, IL10, IL1B, IL6, TNF |
D01583 |
Pirfenidone |
[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |